What Does Teva’s Exit From PhRMA Suggest About Its Priorities?

Teva Insists Its Memberships And Investments Must Be ‘Properly Seated’

Seemingly in one of the first decisions overseen by the company’s new CEO Richard Francis, Teva will not sit at the table of the US brand industry trade association, the Pharmaceutical Research and Manufacturers of America, better known as PhRMA.

Exit
How will Teva approach its novel pipeline under Francis? • Source: Shutterstock

More from Strategy

More from Business